Recent research has shown that certain forms of E. coli bacteria tend to colonize hypoxic areas of the body, including tumors, suggesting they might be playing a role in cancer therapeutics.

A new study reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.

October is Breast Cancer Awareness Month, and the experts at City of Hope Orange County will be donning pink coats in support ...

Recent advancements in cancer treatment, including Precision Medicine, Immunotherapy, and Targeted Therapy, are leading to ...

Updated clinical results to be presented from the ongoing Phase 1/2 ABILITY-1 study of MDNA11 in advanced or metastatic solid tumorsPreclinical ...

A new report from the American Cancer Society says deaths from the disease have fallen nearly 45% compared to 35 years ago. However, new cases continue to rise.

IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based on its T-win ® platform, today announced two ...

Kineta, Inc. (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that its ...

Brown Convention Center A copy of the presentation materials will be added to the “ Publications ” section of the Company’s website at tscan.com once presentations have concluded. TScan is a ...

For Breast Cancer Awareness Month, Oranus Mohammadi, MD, discussed the remarkable progress made in improving survival rates ...

The global PD-1/PD-L1 inhibitors market is projected to witness remarkable growth over the next decade, with an estimated ...